Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc. (REGN) — Form 144: Proposed sale of shares
AI-generated summary
Officer Joseph LaRosa of Regeneron Pharmaceuticals, Inc. filed a proposed sale of 4,466 shares of common stock with an aggregate market value of $4,311,875.12 through broker UBS Financial Services Inc. The approximate date of the sale is November 2, 2026. The shares to be sold stem from a stock option exercise of 9,507 shares on January 3, 2024.
Key facts
- Seller
- Joseph LaRosa
- Relationship
- Officer
- Shares to sell
- 4,466
- Market value
- $4,311,875.12
- Approximate sale date
- Nov 2, 2026
- Broker
- UBS Financial Services Inc
- Acquired
- Jan 3, 2024 · Stock Option Exercise
More REGN filings
- 144
Filed Nov 2, 2026
- 144
Filed Nov 2, 2026
- 144
Filed Oct 30, 2026
- 144
Filed Oct 30, 2026
- 144
Filed Oct 30, 2026
- 10-Q
Filed Oct 30, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.